Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth C de Lange

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 22, 2017
Biomarkers in epilepsy-A modelling perspectiveSven C van Dijkman, Rob A Voskuyl, Elizabeth C de Lange
The AAPS Journal|January 5, 2012
Alteration in P-glycoprotein functionality affects intrabrain distribution of quinidine more than brain entry-a study in rats subjected to status epilepticus by kainateStina Syvänen, Maarten Schenke, Dirk-Jan van den Berg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 13, 2012
Altered GABAA receptor density and unaltered blood-brain barrier transport in a kainate model of epilepsy: an in vivo study using 11C-flumazenil and PETStina Syvänen, Maaike Labots, Yoshihiko Tagawa, et al.
Nuclear Medicine and Biology|January 10, 2012
Synthesis and preclinical evaluation of [11C]D617, a metabolite of (R)-[11C]verapamilJoost Verbeek, Stina Syvänen, Robert C Schuit, et al.
Neuroimage|May 26, 2011
Simultaneous in vivo measurements of receptor density and affinity using [11C]flumazenil and positron emission tomography: comparison of full saturation and steady state methodsStina Syvänen, Elizabeth C de Lange, Yoshihiko Tagawa, et al.
BMC Medical Imaging|January 5, 2011
(R)-[11C]verapamil PET studies to assess changes in P-glycoprotein expression and functionality in rat blood-brain barrier after exposure to kainate-induced status epilepticusStina Syvänen, Gert Luurtsema, Carla F M Molthoff, et al.
EJNMMI Radiopharmacy and Chemistry|October 9, 2018
Synthesis and preliminary preclinical evaluation of fluorine-18 labelled isatin-4-(4-methoxyphenyl)-3-thiosemicarbazone ([<sup>18</sup>F]4FIMPTC) as a novel PET tracer of P-glycoprotein expressionJoost Verbeek, Jonas Eriksson, Stina Syvänen, et al.
Nuclear Medicine and Biology|July 6, 2013
[11C]quinidine and [11C]laniquidar PET imaging in a chronic rodent epilepsy model: impact of epilepsy and drug-responsivenessStina Syvänen, Vera Russmann, Joost Verbeek, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 22, 2017
Biomarkers in epilepsy-A modelling perspectiveSven C van Dijkman, Rob A Voskuyl, Elizabeth C de Lange
The AAPS Journal|January 5, 2012
Alteration in P-glycoprotein functionality affects intrabrain distribution of quinidine more than brain entry-a study in rats subjected to status epilepticus by kainateStina Syvänen, Maarten Schenke, Dirk-Jan van den Berg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 13, 2012
Altered GABAA receptor density and unaltered blood-brain barrier transport in a kainate model of epilepsy: an in vivo study using 11C-flumazenil and PETStina Syvänen, Maaike Labots, Yoshihiko Tagawa, et al.
Nuclear Medicine and Biology|January 10, 2012
Synthesis and preclinical evaluation of [11C]D617, a metabolite of (R)-[11C]verapamilJoost Verbeek, Stina Syvänen, Robert C Schuit, et al.
Neuroimage|May 26, 2011
Simultaneous in vivo measurements of receptor density and affinity using [11C]flumazenil and positron emission tomography: comparison of full saturation and steady state methodsStina Syvänen, Elizabeth C de Lange, Yoshihiko Tagawa, et al.
BMC Medical Imaging|January 5, 2011
(R)-[11C]verapamil PET studies to assess changes in P-glycoprotein expression and functionality in rat blood-brain barrier after exposure to kainate-induced status epilepticusStina Syvänen, Gert Luurtsema, Carla F M Molthoff, et al.
EJNMMI Radiopharmacy and Chemistry|October 9, 2018
Synthesis and preliminary preclinical evaluation of fluorine-18 labelled isatin-4-(4-methoxyphenyl)-3-thiosemicarbazone ([<sup>18</sup>F]4FIMPTC) as a novel PET tracer of P-glycoprotein expressionJoost Verbeek, Jonas Eriksson, Stina Syvänen, et al.
Nuclear Medicine and Biology|July 6, 2013
[11C]quinidine and [11C]laniquidar PET imaging in a chronic rodent epilepsy model: impact of epilepsy and drug-responsivenessStina Syvänen, Vera Russmann, Joost Verbeek, et al.
Pageof 1